Clinical Trial Update: Open Label Study in Adolescents and Children With Myotonic Disorders [Phase 3]

View source ↗

Summary

Open-label Phase 3 study in children and adolescents with myotonic dystrophy has completed, sponsored by Lupin Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy

Snippet

Sponsor: Lupin Ltd. | Conditions: Myotonic Dystrophy | Phase 3 | Status: COMPLETED